Anhui Fengyuan Pharmaceutical Co., Ltd.

000153

CNE0000014X5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 16/06/2024 BST			5-day change	1st Jan Change
5.54 ^CNY	-0.36%		-1.25%	-17.23%

05-30	Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024	CI
05-23	Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI

Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023

May 22, 2024

Anhui Fengyuan Pharmaceutical Co., Ltd. at the Annual General Meeting of 2023 held on 22 May 2024 approved a cash dividend/10 shares (tax included) of CNY 1.50000000 for the year 2023.

Latest news about Anhui Fengyuan Pharmaceutical Co., Ltd.

Anhui Fengyuan Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 07 June 2024	05-30	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	05-22	CI
Fengyuan Pharma Gets Nod to Register Two Dialysis Solutions	05-13	MT
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	04-26	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. canceled the acquisition of Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	19/06/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 16, 2023	09/06/23	CI
Anhui Fengyuan Pharmaceutical Announces Cash Dividend for 2022	19/05/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend (Tax Included) for 2022	20/04/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/04/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. agreed to acquire Anhui Tiger Biotech Co., Ltd. from Anhui Taige Biological Technology Co., Ltd.	07/04/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. announced a financing transaction	02/01/23	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire Anhui Fengyuan Gelatin Co., Ltd. from BBCA Group Co., Ltd. for approximately CNY 308 million.	11/10/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Management Appointments	08/07/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 05 July 2022	29/06/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Approves Cash Distribution for 2021	26/05/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	29/04/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
Anhui Fengyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

Duration

Period

Chart Anhui Fengyuan Pharmaceutical Co., Ltd.

More charts

ANHUI FENGYUAN PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, manufacture and distribution of biological medicines, chemical synthetic medicines and Chinese medicines. The Company's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The Company is also engaged in the retailing and wholesale of drugs. The Company conducts its businesses mainly in domestic markets, with Anhui province as its main market.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD.	-17.23%	356M
ELI LILLY AND COMPANY	+52.33%	791B
NOVO NORDISK A/S	+40.45%	630B
MERCK & CO., INC.	+16.96%	328B
ABBVIE INC.	+9.27%	298B
ASTRAZENECA PLC	+17.25%	246B
ROCHE HOLDING AG	+0.41%	225B
NOVARTIS AG	+10.22%	218B
AMGEN INC.	+4.60%	160B
PFIZER, INC.	-6.06%	156B

Other Pharmaceuticals